Zobrazeno 1 - 10
of 367
pro vyhledávání: '"M, Stecker"'
Autor:
Allison B. Reiss, Caitriona Greene, Christopher Dayaramani, Steven H. Rauchman, Mark M. Stecker, Joshua De Leon, Aaron Pinkhasov
Publikováno v:
Neurology International, Vol 15, Iss 3, Pp 821-841 (2023)
SARS-CoV-2, a single-stranded RNA coronavirus, causes an illness known as coronavirus disease 2019 (COVID-19). Long-term complications are an increasing issue in patients who have been infected with COVID-19 and may be a result of viral-associated sy
Externí odkaz:
https://doaj.org/article/72f81cf224624df2ab1fad61fd14aef8
Publikováno v:
Heliyon, Vol 9, Iss 8, Pp e18671- (2023)
Quickly and efficiently extracting evoked potential information from noise is critical to the clinical practice of intraoperative neurophysiologic monitoring (IONM). Currently this is primarily done using trained professionals to interpret averaged w
Externí odkaz:
https://doaj.org/article/8d27e475414a40ddbebf3fc696af04ff
Autor:
Allison B. Reiss, Shelly Gulkarov, Benna Jacob, Ankita Srivastava, Aaron Pinkhasov, Irving H. Gomolin, Mark M. Stecker, Thomas Wisniewski, Joshua De Leon
Publikováno v:
Life, Vol 14, Iss 2, p 196 (2024)
Alzheimer’s disease (AD) is a progressive and incurable neurodegenerative disorder that primarily affects persons aged 65 years and above. It causes dementia with memory loss and deterioration in thinking and language skills. AD is characterized by
Externí odkaz:
https://doaj.org/article/d67b9fe6fcc340d7840a20d697193d4f
Publikováno v:
AIMS Public Health, Vol 9, Iss 3, Pp 618-629 (2022)
Despite intensive research, effective treatments for many common and devastating diseases are lacking. For example, huge efforts and billions of dollars have been invested in Alzheimer's disease (AD), which affects over 50 million people worldwide. H
Externí odkaz:
https://doaj.org/article/9f6eab0c99c4423bbea45b35243d341b
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 19, p 14488 (2023)
Although there are many biochemical methods to measure amyloid-β (Aβ)42 concentration, one of the critical issues in the study of the effects of Aβ42 on the nervous system is a simple physiological measurement. The in vitro rat sciatic nerve model
Externí odkaz:
https://doaj.org/article/e2c571252f63420a8570f2ab72b18d23
Autor:
Pamela M. Stecker, Anne Foegen
Publikováno v:
Frontiers in Education, Vol 7 (2022)
A brief overview of the development of an online system to support algebra progress monitoring across several years of an iterative process of development, feedback, and revision is provided. Online instructional modules addressed progress monitoring
Externí odkaz:
https://doaj.org/article/3d3d7e38c0964eaea34a7f6a7114c4c4
Autor:
Allison B. Reiss, Dalia Muhieddine, Berlin Jacob, Michael Mesbah, Aaron Pinkhasov, Irving H. Gomolin, Mark M. Stecker, Thomas Wisniewski, Joshua De Leon
Publikováno v:
Medicina, Vol 59, Iss 6, p 1084 (2023)
As the search for modalities to cure Alzheimer’s disease (AD) has made slow progress, research has now turned to innovative pathways involving neural and peripheral inflammation and neuro-regeneration. Widely used AD treatments provide only symptom
Externí odkaz:
https://doaj.org/article/47c3169ae4524ad1a119aa0bb9fa7c57
Autor:
John A. Olsen, Lauren A. Kenna, Regine C. Tipon, Michael G. Spelios, Mark M. Stecker, Eitan M. Akirav
Publikováno v:
EBioMedicine, Vol 10, Iss C, Pp 227-235 (2016)
Multiple sclerosis (MS) is a neurodegenerative disease of the central nervous system (CNS). Minimally invasive biomarkers of MS are required for disease diagnosis and treatment. Differentially methylated circulating-free DNA (cfDNA) is a useful bioma
Externí odkaz:
https://doaj.org/article/2f52b81ca96c44a088633b9229625d60
Autor:
Mark M, Stecker, Inna, Keselman
Publikováno v:
Handbook of clinical neurology. 186
Although cardiac and aortic operations have been successfully performed for more than 60 years, the risk of neurologic complications remains high. In particular, the rate of stroke with cardiac operations continues to be significant in the 1%-5% rang
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::145c7b8b53c0f593cf08e0d38a3ecb93
https://pubmed.ncbi.nlm.nih.gov/35772898
https://pubmed.ncbi.nlm.nih.gov/35772898
Autor:
Irving H. Gomolin, Mark M. Stecker, Aaron Pinkhasov, Amy D Glass, Joshua DeLeon, Hirra A Arain, Natalie Montufar, Allison B. Reiss
Publikováno v:
The Neurologist. 26:52-61
Background The goal of slowing or halting the development of Alzheimer disease (AD) has resulted in the huge allocation of resources by academic institutions and pharmaceutical companies to the development of new treatments. The etiology of AD is elu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::023e797a1c64a9c58363a84823bf9a96
https://doi.org/10.1097/nrl.0000000000000320
https://doi.org/10.1097/nrl.0000000000000320